IDD Daily Brief: Monday, Oct 19, 2026 — Copart ties its CEO's pay to a 20 million-share option as IonQ raises $2 billion

The Big Picture

• Copart put its CEO's pay on the line. The board granted Jay Adair an option on 20 million shares with exercise prices from $26.27 to $52.54, meant to be his only substantive pay for 10 years alongside a $1 salary, if stockholders approve it.

• IonQ raised about $2 billion. The company closed an offering of 20.5 million shares and 29.5 million pre-funded warrants at a combined $40.00, attaching 100 million Series C warrants exercisable at $69.46.

• Two executives cashed in under trading plans. Moderna President Stephen Hoge sold about $17.0 million of stock and Natera Executive Chairman Matthew Rabinowitz sold about $20.1 million, both after exercising long-held options.

Since Friday

Most of the news since Friday's Week in Review came from filings made late Friday. Five stories cleared the IDD newsroom's bar: one earnings report, two company announcements and two large insider sales, all detailed below.

Earnings

Reported since Friday's issue

• First Financial Bankshares (FFIN): The Texas lender posted record third-quarter net income of $74.31 million, or $0.52 per diluted share, up from $52.27 million, or $0.36, a year earlier, according to its 8-K. Net interest margin widened to 3.91% from 3.80%, the provision for credit losses fell to $2.03 million from $24.44 million, and the quarterly dividend is $0.22, up from $0.19 a year ago.

Company News

• Copart (CPRT) approved a stand-alone option for CEO A. Jayson Adair on 20 million shares, in four 5 million-share tranches with exercise prices of $26.27, $35.03, $43.78 and $52.54, according to its 8-K. Adair would draw a $1 annual salary. The option vests after five years of service as CEO, runs 10 years and is forfeited if stockholders do not approve it.

• IonQ (IONQ) closed an underwritten offering on Oct. 16 in which each share and pre-funded warrant came with two Series C warrants, raising roughly $2 billion at the public price, the company said in an 8-K. The 100 million Series C warrants run for seven years, and J.P. Morgan Securities was sole underwriter.

Insider & Institutional Watch

• Moderna (MRNA): President Stephen Hoge exercised 152,905 options at $12.21 and sold 78,369 shares on Oct. 14 and 15 at weighted-average prices of $213.47 to $220.72, about $17.0 million in all, according to a Form 4 filing. The trades were made under a 10b5-1 plan adopted June 15, and he held 1,636,565 shares directly afterward.

• Natera (NTRA): Executive Chairman Matthew Rabinowitz exercised 50,000 options at $10.41 and sold 50,000 shares on Oct. 15 at weighted-average prices of $388.32 to $408.24, about $20.1 million in all, according to a Form 4 filing. The sales were made under a 10b5-1 plan adopted June 12, leaving his direct stake at 2,119,394 shares.

The Week Ahead

• Tuesday, Oct. 20, 10:00 AM ET: The Bureau of Labor Statistics releases State Employment and Unemployment for September.

• Wednesday, Oct. 21, 10:00 AM ET: The Bureau of Labor Statistics releases Usual Weekly Earnings of Wage and Salary Workers for the third quarter.

• Looking further out: The Bureau of Economic Analysis schedules its advance estimate of third-quarter GDP for Thursday, Oct. 29, at 8:30 AM ET.

This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.

Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.